Phico Therapeutics

Phaxiam

The company develops bacteriophage-based treatments to combat antibiotic-resistant bacterial infections for patients with severe hospital-acquired or chronic respiratory conditions.

Phage therapy treatment

This company develops personalised bacteriophage cocktails and diagnostic susceptibility tests for patients suffering from multidrug-resistant bacterial infections.

Telum Therapeutics

Telum Therapeutics develops engineered phage lytic proteins to treat multidrug-resistant bacterial infections for patients with hospital-acquired and ventilator-associated pneumonia.

Felix Biotech

Felix Biotechnology develops engineered bacteriophage therapies to treat drug-resistant bacterial infections for patients with chronic diseases and partners in the skin care industry.

Locus Biosciences

This biotechnology company develops engineered bacteriophage therapies for patients with drug-resistant bacterial infections using CRISPR technology and artificial intelligence.

Phagos

The company develops AI-powered bacteriophage treatments to combat antibiotic-resistant bacterial diseases, primarily for the animal farming and healthcare sectors.

Infex Therapeutics

The company develops and licences antibacterial and antiviral drugs for pharmaceutical partners and healthcare providers to treat life-threatening infections and antimicrobial resistance.

PRECISIONPHAGE

This company provides bacteriophage bioinformatics software and laboratory services for researchers, phage producers, and the healthcare industry to combat antimicrobial resistance.